The CDG is mandated with providing sustainable and scalable clinical diagnostic genomic testing for the BC population. The CDG aims to implement emerging technologies to provide the most cost-effective clinical testing for genetic disease. The CDG will embrace personalized medicine through a strong integration of technology and informatics. The CDG will be the premier centre for clinical diagnostic genomics in Canada.

The CDG is proud to have the support of key partners including the following:

The Centre for Clinical Diagnostic Genomics (CDG) is based within Canada's Michael Smith Genome Sciences Centre (GSC) and is supported by the Provincial Health Services Authority (PHSA). Further partnerships with the clinical laboratories of the Lower Mainland Pathology & Laboratory Medicine Services including the Cancer Genetics Laboratory provide extensive diagnostic experience and consultation. These partners work together to ensure timely and accurate delivery of clinically-actionable information required to ensure excellent patient care.

Clinical diagnostic genomic testing is rapidly becoming a standard of care for many hereditary and acquired conditions and this integrated partnership will see that demand met with quality service provision. As this testing demand grows, we require novel strategies to address testing capacity and capability. The CDG is well-placed to implement novel genomic technologies, and harness the significant bioinformatic expertise residing at the GSC for data analysis and interpretation.

The GSC has extensive, world-renowned expertise in adopting cutting edge technology for genomics applications combined with innovative and internationally-recognized bioinformatic capabilities. The CDG provides high throughput sequencing for genomic diagnostics in CAP (College of American Pathologists) accredited laboratories. The combination of technical, informatic and clinical expertise ensures that genomic diagnostics will be delivered with high-quality and confidence.

© 2012 Centre for Clinical Diagnostic Genomics
contact: